December 17, 2021 Comments Off on New patent for Tetraphase Pharms drug XERAVA Posted in: Patent Added Annual Drug Patent Expirations for XERAVA Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…
The post New patent for Tetraphase Pharms drug XERAVA appeared first on Drug…
December 17, 2021 Comments Off on New patent expiration for Allergan drug BYSTOLIC Posted in: Uncategorized
Annual Drug Patent Expirations for BYSTOLIC Bystolic is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There is one patent protecting…
The post New patent expiration for Allergan drug BYSTOLIC appeared fir…
